Clinical trial
CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With…
NCT00346801 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00346801 |
|---|---|
| Title | CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) |
| Official title | A Phase I Study of Concurrent CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Comprehensive Cancer Network |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Celecoxib, Cisplatin, CPT-11, Concurrent Thoracic Radiation Therapy |
| Enrollment | 20 |
| Start date | Sep 1, 2003 |
| Primary completion | Oct 1, 2012 |
| First posted | Jun 30, 2006 |
| Last update posted | Oct 22, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: